Ranbaxy Mexico to market Daiichi Sankyo products in Mexico
Ranbaxy Laboratories Limited and Daiichi Sankyo Company Limited announced that the portfolio of Daiichi Sankyo would be commercialized in Mexico through a recently created marketing Division within Ranbaxy Mexico SA de CV, a subsidiary of Ranbaxy. This is the first time in Latin America that Daiichi Sankyo and Ranbaxy are leveraging mutual synergies generated through the Hybrid Business Model.
Comments